Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes.
BACKGROUND
The low incidence of sarcomas in the general population makes heritable contribution to disease risk difficult to discern beyond highly penetrant Mendelian syndromes.


METHODS
The Utah Cancer Registry (UCR) and Utah Population Database were interrogated for sarcoma diagnostic codes grouped by genetic type, either complex genotype/karyotype sarcoma or balanced translocation-associated sarcoma. The genealogic index of familiality (GIF) was calculated and relative risks (RR) of disease estimated for first-, second-, and third-degree relatives of sarcoma probands. Cancer patterns in pedigrees of sarcoma probands were examined to rule out known hereditary cancer syndromes.


RESULTS
A total of 229 balanced translocation type and 1,161 complex genotype type sarcomas with at least three generations of ancestral genealogy data were identified in the UCR. There was no evidence for excess relatedness for the balanced translocation group by using the GIF test (P = 0.657) and no significantly elevated RRs. In the complex genotype group, we observed significantly elevated GIF (P = 0.03). Modest RRs corroborated the GIF analysis, in which excess relatedness existed in distant relationships. No recognized cancer syndromes were identified among high-risk pedigrees.


CONCLUSIONS
We identified strong familiality among complex genotype sarcomas, independent from known cancer predisposition syndromes. In the absence of significantly elevated RRs for close relatives, the high GIF argues for a strong genetic-rather than environmental-component to complex genotype sarcoma risk. We observed no significant familial risk of developing balanced translocation-associated sarcomas, but the sample was small.


CONCLUSIONS
There exists yet to be deciphered heritable risk for developing complex genotype sarcomas.
Sarcoma Services, Department of Orthopaedics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA. kevin.jones@hci.utah.edu
Kevin B
KB
Jones
Joshua D
JD
Schiffman
Wendy
W
Kohlmann
R Lor
RL
Randall
Stephen L
SL
Lessnick
Lisa A
LA
Cannon-Albright
D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D006801:Humans; D015994:Incidence; D008297:Male; D008957:Models, Genetic; D015233:Models, Statistical; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D010375:Pedigree; D012307:Risk Factors; D012509:Sarcoma / Q000235:genetics*
An Pediatr (Barc). 2005 Dec;63(6):537-47
16324620
J Oncol. 2010;2010:397632
20300555
Hum Reprod. 2002 Mar;17(3):555-9
11870102
J Infect Dis. 2008 Jan 1;197(1):18-24
18171280
Am J Epidemiol. 1987 Oct;126(4):578-86
3631049
Int J Cancer. 2005 Nov 20;117(4):655-61
15929077
Cancer Metastasis Rev. 1990 Sep;9(2):125-36
2253312
Cancer Lett. 1987 Oct;37(1):17-24
3664449
Lancet. 1975 Jan 25;1(7900):195-7
47422
Prostate. 2005 Sep 1;64(4):347-55
15754348
Circulation. 2004 Nov 9;110(19):3143-8
15520309
Am J Surg. 1964 Apr;107:598-603
14136345
Cancer. 1984 May 1;53(9):1959-62
6704922
Ophthalmologica. 1977;175(4):185-91
268552
Cancer. 2009 Aug 1;115(15):3526-36
19548262
J Natl Cancer Inst. 2010 Aug 18;102(16):1272-83
20656964
Ann Hum Genet. 1989 Oct;53(4):339-55
2624429
J Neurosurg. 2003 Oct;99(4):637-43
14567597
J Cell Physiol Suppl. 1984;3:63-77
6589230
Cancer Res. 1988 Sep 15;48(18):5358-62
3409256
Am J Clin Oncol. 1986 Aug;9(4):358-60
3751974
Hum Hered. 2008;65(4):209-20
18073491
Eur J Cancer. 2006 Sep;42(14):2343-9
16859907
Orphanet J Rare Dis. 2010 Jan 29;5:2
20113479
Surg Clin North Am. 2008 Jun;88(3):451-81, v
18514694
Comput Biomed Res. 1999 Dec;32(6):517-29
10587469
Lancet Oncol. 2005 Jul;6(7):485-90
15992697
Int J Cancer. 2003 Jul 20;105(6):825-30
12767069
Pediatrics. 2009 Jan;123(1):124-33
19117870
JAMA. 1986 Sep 5;256(9):1141-7
3801091
Am J Hum Biol. 1999;11(2):167-174
11533940
Am J Hum Genet. 1984 Jul;36(4):836-57
6591796
Cancer Res. 1994 May 1;54(9):2378-85
8162584
Am Heart J. 2006 Aug;152(2):305-11
16875915
Cancer. 1993 May 1;71(9):2847-53
8467462
Cancer. 1979 Feb;43(2):679-89
217526
Med Princ Pract. 2008;17(1):84-5
18059108
J Natl Cancer Inst. 1994 Nov 2;86(21):1600-8
7932824
Med Sci Monit. 2006 Dec;12(12):BR385-396
17136003